Taysha Gene Therapies (TSHA) Asset Utilization Ratio (2023 - 2026)

Taysha Gene Therapies has disclosed Asset Utilization Ratio across 4 years of filings, most recently posting 0.01 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.01, down 79.45% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01 (down 79.45% YoY), and the FY2025 annual result was 0.02, down 56.35% from the prior year.
• Asset Utilization Ratio came in at 0.01 for Q1 2026 at Taysha Gene Therapies, down from 0.02 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.09 in Q1 2024 to a low of 0.01 in Q1 2026.
• The 4-year median for Asset Utilization Ratio is 0.05 (2024), against an average of 0.05.
• Across the five-year window, Asset Utilization Ratio tumbled 41.65% in 2024 and tumbled 79.45% in 2026, its largest moves.
• Taysha Gene Therapies' Asset Utilization Ratio stood at 0.08 in 2023, then tumbled by 41.65% to 0.05 in 2024, then slumped by 65.93% to 0.02 in 2025, then plunged by 40.39% to 0.01 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.01 (Q1 2026), 0.02 (Q4 2025), and 0.02 (Q3 2025), per Business Quant data.